• enVVeno Medical highlighted a newly issued U.S. patent covering its enVVe system, expanding its intellectual property protection.
• The company framed the patent as strengthening barriers to entry ahead of its FDA IDE-approved pivotal trial for a non-surgical replacement venous valve.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. enVVeno Medical Corp. published the original content used to generate this news brief on July 15, 2026, and is solely responsible for the information contained therein.